A novel modified dynamic conformal arc technique for treatment of peripheral lung tumors using stereotactic body radiation therapy

Practical Radiation Oncology

Volumn 1, Issue 2, 2011, Pages 126-134

  Ross, Christopher C ^a   Kim, John J ^a   Chen, Zhe J ^a   Grew, David J ^b   Chang, Bryan W ^a   Decker, Roy H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MODIFIED DYNAMIC CONTROL ARC TECHNIQUE; PRIORITY JOURNAL; RADIATION DOSE; RADIOLOGICAL PROCEDURES; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84865701224     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2010.11.002     Document Type: Article

References (15)

1. Ginsberg R.J., Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg 1995, 60:615-623.
2. Fakiris A.J., McGarry R.C., Yiannoutsos C.T., et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009, 75:677-682.
3. Baumann P., Nyman J., Lax I., et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006, 45:787-795.
4. Baumann P., Nyman J., Hoyer M., et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009, 27:3290-3296.
5. Nagata Y., Negoro Y., Aoki T., et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002, 52:1041-1046.
6. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63:1427-1431.
7. Hara R., Itami J., Kondo T., et al. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer 2006, 106:1347-1352.
8. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2:S94-S100.
9. Timmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303(11):1070-1076.
10. Xia T., Li H., Sung Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 66:117-125.
11. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24:4833-4839.
12. Paddick I. A simple scoring ratio to index the conformity of radiosurgical treatment plans. J Neurosurg 2000, 93(Suppl 3):219-222.
13. Lim D.H., Yi B.Y., Mirmiran A., et al. Optimal beam arrangement for sterotactic body radiation therapy delilvery in lung tumors. Acta Oncol 2010, 49:219-224.
14. McGrath S.D., Matuszak M.M., Yan D., et al. Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: a dosimetric and treatment efficiency analysis. Radiother Oncol 2010, 95:153-157.
15. Cardinale R.M., Wu Q., Benedict S.H., et al. Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 1999, 45:515-520.